Literature DB >> 19291181

Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.

Marina G Silveira1, Flavia D Mendes, Nancy N Diehl, Felicity T Enders, Keith D Lindor.   

Abstract

BACKGROUND/AIMS: Primary biliary cirrhosis (PBC) is frequently associated with autoimmune diseases, including thyroid disease, although it is uncertain that this association is higher than in other liver diseases.
METHODS: We compared the prevalence and incidence of thyroid dysfunction (TD) in a series of patients with PBC (n=67) with patients with primary sclerosing cholangitis (PSC) (n=79) and non-alcoholic fatty liver disease (NAFLD) (n=97) seen in a tertiary referral centre who had previously participated in clinical trials.
RESULTS: At initial evaluation, prevalence of TD in PBC was 13% compared with 11% in PSC (P=0.71) and 25% in NAFLD (P=0.08). Incidence of TD was 2.9 patients per 100 person-years in PBC compared with 2.1 patients per 100 person-years in PSC (P=0.57) and 1.8 patients per 100 person-years in non-alcoholic liver disease (P=0.45). Older age, female gender, biochemical abnormalities and concurrent autoimmune disorders were not predictive of the development of TD.
CONCLUSIONS: TD was unexpectedly as common in patients with PBC as in patients with PSC and NAFLD, yet significantly more common than expected in the general population. Further investigation of thyroid disease in PSC and NAFLD is warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19291181     DOI: 10.1111/j.1478-3231.2009.02003.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  37 in total

1.  Immunological regulation of metabolism--a novel quintessential role for the immune system in health and disease.

Authors:  Jeremy S Schaefer; John R Klein
Journal:  FASEB J       Date:  2010-09-08       Impact factor: 5.191

2.  Prevalence of hypothyroidism in nonalcoholic fatty liver disease in patients attending a tertiary hospital in western India.

Authors:  Pathik Parikh; Aniruddha Phadke; Prabha Sawant
Journal:  Indian J Gastroenterol       Date:  2015-04-16

3.  Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers.

Authors:  Annarosa Floreani; Chiara Mangini; Anna Reig; Irene Franceschet; Nora Cazzagon; Lisa Perini; Llorenç Caballería; Silvia Cocchio; Vincenzo Baldo; Albert Parés
Journal:  Am J Gastroenterol       Date:  2016-10-25       Impact factor: 10.864

4.  Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses.

Authors:  Elvira Alonso-Merino; Rosa Martín Orozco; Lidia Ruíz-Llorente; Olaia A Martínez-Iglesias; Juan Pedro Velasco-Martín; Ana Montero-Pedrazuela; Luisa Fanjul-Rodríguez; Constanza Contreras-Jurado; Javier Regadera; Ana Aranda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

5.  Prevalence of hypothyroidism in nonalcoholic fatty liver disease.

Authors:  Mangesh R Pagadala; Claudia O Zein; Srinivasan Dasarathy; Lisa M Yerian; Rocio Lopez; Arthur J McCullough
Journal:  Dig Dis Sci       Date:  2011-12-20       Impact factor: 3.199

6.  Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner.

Authors:  Andrew C Adams; Inna Astapova; Ffolliott M Fisher; Michael K Badman; Katherine E Kurgansky; Jeffrey S Flier; Anthony N Hollenberg; Eleftheria Maratos-Flier
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

7.  Prevalence and clinical implications of positive serum anti-microsomal antibodies in symptomatic patients with ileal pouches.

Authors:  Udayakumar Navaneethan; Preethi G K Venkatesh; Elena Manilich; Ravi P Kiran; Feza H Remzi; Bo Shen
Journal:  J Gastrointest Surg       Date:  2011-06-30       Impact factor: 3.452

Review 8.  Cross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatment.

Authors:  Yue-Ye Huang; Aaron M Gusdon; Shen Qu
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

Review 9.  Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.

Authors:  Renato Tozzoli; Maria Concetta Sorrentino; Nicola Bizzaro
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 10.  Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.

Authors:  Ahad Eshraghian; Alireza Hamidian Jahromi
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.